Search

Search Constraints

You searched for: Author/Creator Bajetta, Emilio

Search Results

1. A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors. Issue 6 (June 2018)

2. Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study. Issue 4 (March 2015)

3. Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study. Issue 4 (March 2015)

4. Everolimus in combination with octreotide long‐acting repeatable in a first‐line setting for patients with neuroendocrine tumors: An ITMO group study. Issue 16 (18th April 2014)

5. Everolimus in combination with octreotide long‐acting repeatable in a first‐line setting for patients with neuroendocrine tumors: An ITMO group study. Issue 16 (18th April 2014)

6. Everolimus Plus Octreotide Long‐Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT‐2 Study. (21st December 2012)

7. Impact on Survival of Timing and Duration of Adjuvant Chemotherapy in Radically Resected Gastric Cancer. Issue 4 (July 2016)

8. Safety profile and treatment response of everolimus in different solid tumors: an observational study. (July 2014)

9. Safety profile and treatment response of everolimus in different solid tumors: an observational study. (July 2014)

10. The role of Geriatric screening tool (G8) in predicting side effect in older patients during therapy with aromatase inhibitor. Issue 2 (March 2019)